Immune response to the 23-valent pneumococcal polysaccharide vaccine in lymphoma patients and patients with chronic renal diseases.
Kühnemund
O
O
Institute of Medical Microbiology, University Hospital, Aachen, Federal Republic of Germany.
Stütz
A
A
Fuchshuber
A
A
Querfeld
U
U
Petrasch
S
S
Reinert
R R
RR
Lütticken
R
R
D000293:Adolescent; D000328:Adult; D000907:Antibodies, Bacterial / Q000096:biosynthesis / Q000097:blood; D001428:Bacterial Vaccines / Q000494:pharmacology*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007674:Kidney Diseases / Q000276:immunology*; D007676:Kidney Failure, Chronic / Q000276:immunology; D008223:Lymphoma / Q000276:immunology*; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000276:immunology; D022242:Pneumococcal Vaccines; D011135:Polysaccharides, Bacterial / Q000276:immunology; D013296:Streptococcus pneumoniae / Q000276:immunology*; D013997:Time Factors
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D022242:Pneumococcal Vaccines; D011135:Polysaccharides, Bacterial